Works matching Adrenocortical cancer
Results: 358
Factors Affecting Survival in Adrenocortical Cancers: Single-Center Experience.
- Published in:
- Turkish Journal of Endocrinology & Metabolism, 2020, v. 24, n. 3, p. 221, doi. 10.25179/tjem.2020-74861
- By:
- Publication type:
- Article
Interplay between Immune Cell Infiltration and Tumor Histological Subtype: A Case of Adrenocortical Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5303, doi. 10.3390/cancers14215303
- By:
- Publication type:
- Article
Prognostic factors and mitotane treatment of adrenocortical cancer. Two decades of experience from an institutional case series.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.952418
- By:
- Publication type:
- Article
Outcome of operation in patients with adrenocortical cancer invading the inferior vena cava-a European Society of Endocrine Surgeons (ESES) survey.
- Published in:
- Langenbeck's Archives of Surgery, 2012, v. 397, n. 2, p. 225, doi. 10.1007/s00423-011-0876-6
- By:
- Publication type:
- Article
Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1406616
- By:
- Publication type:
- Article
Pembrolizumab-Induced Lichen Planus Pemphigoides in a Patient with Metastatic Adrenocortical Cancer: A Case Report and Literature Review.
- Published in:
- Dermatopathology, 2023, v. 10, n. 3, p. 244, doi. 10.3390/dermatopathology10030033
- By:
- Publication type:
- Article
MiR‐483‐5p and miR‐139‐5p promote aggressiveness by targeting N‐myc downstream‐regulated gene family members in adrenocortical cancer.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 4, p. 944, doi. 10.1002/ijc.31363
- By:
- Publication type:
- Article
Antitumoral effects of 9- cis retinoic acid in adrenocortical cancer.
- Published in:
- Cellular & Molecular Life Sciences, 2014, v. 71, n. 5, p. 917, doi. 10.1007/s00018-013-1408-z
- By:
- Publication type:
- Article
Preclinical Models of Adrenocortical Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2873, doi. 10.3390/cancers15112873
- By:
- Publication type:
- Article
Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02464-5
- By:
- Publication type:
- Article
Case Report: Complete Necrosis of a Large Adrenocortical Cancer and Liver Metastases Achieved by Selective Arterial Embolization: A Case Study and Review of Literature.
- Published in:
- Frontiers in Endocrinology, 2021, v. 11, p. N.PAG, doi. 10.3389/fendo.2021.677187
- By:
- Publication type:
- Article
Estrogen Related Receptor Alpha (ERRα) a Bridge between Metabolism and Adrenocortical Cancer Progression.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3885, doi. 10.3390/cancers14163885
- By:
- Publication type:
- Article
Non-Coding RNAs in Adrenocortical Cancer: From Pathogenesis to Diagnosis.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 461, doi. 10.3390/cancers12020461
- By:
- Publication type:
- Article
Central Hypothyroidism is Frequent During Mitotane Therapy in Adrenocortical Cancer Patients: Prevalence and Timeline.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 9, p. 2336, doi. 10.1210/clinem/dgad115
- By:
- Publication type:
- Article
Complete Remission of Advanced Adrenocortical Cancer Following Mitotane Monotherapy: A Case Report and Literature Review of Predictive Markers.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.680853
- By:
- Publication type:
- Article
Diagnosis, treatment and outcome of adrenocortical cancer.
- Published in:
- British Journal of Surgery, 2015, v. 102, n. 4, p. 291, doi. 10.1002/bjs.9743
- By:
- Publication type:
- Article
Results of the treatment of adrenocortical cancer patients at the Maria Sklodowska-Curie National Research Institute of Oncology – Krakow Branch.
- Published in:
- Nowotwory, 2023, v. 73, n. 2, p. 63, doi. 10.5603/NJO.2023.0015
- By:
- Publication type:
- Article
Adenocarcinoma de corteza suprarrenal.
- Published in:
- Revista de Sanidad Militar, 2008, v. 62, n. 6, p. 292
- By:
- Publication type:
- Article
Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape.
- Published in:
- BMC Medical Genomics, 2020, v. 13, n. 1, p. N.PAG, doi. 10.1186/s12920-020-00809-7
- By:
- Publication type:
- Article
Response to Immunotherapy in Combination With Mitotane in Patients With Metastatic Adrenocortical Cancer.
- Published in:
- Journal of the Endocrine Society, 2019, v. 3, n. 12, p. 2295, doi. 10.1210/js.2019-00305
- By:
- Publication type:
- Article
Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening.
- Published in:
- Journal of Translational Medicine, 2012, v. 10, n. 1, p. 198, doi. 10.1186/1479-5876-10-198
- By:
- Publication type:
- Article
IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer.
- Published in:
- Endocrine (1355008X), 2019, v. 64, n. 3, p. 673, doi. 10.1007/s12020-019-01869-1
- By:
- Publication type:
- Article
CHEMOTHERAPY OF ADRENOCORTICAL CANCER WITH o,p'DDD.
- Published in:
- Annals of Internal Medicine, 1960, v. 53, n. 4, p. 672, doi. 10.7326/0003-4819-53-4-672
- By:
- Publication type:
- Article
Is There a Role of Targeted Agents in the Management of Adrenocortical Cancers?
- Published in:
- Case Reports in Endocrinology, 2012, p. 1, doi. 10.1155/2012/875764
- By:
- Publication type:
- Article
Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Signaling Pathways in Adrenocortical Cancer.
- Published in:
- Annals of the New York Academy of Sciences, 2002, v. 968, n. 1, p. 222, doi. 10.1111/j.1749-6632.2002.tb04338.x
- By:
- Publication type:
- Article
Long-term survival after bilateral adrenalectomy for metachronous adrenocortical cancer.
- Published in:
- International Journal of Urology, 2004, v. 11, n. 12, p. 1127, doi. 10.1111/j.1442-2042.2004.00963.x
- By:
- Publication type:
- Article
Bridging the Scientific Gaps to Identify Effective Treatments in Adrenocortical Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5245, doi. 10.3390/cancers14215245
- By:
- Publication type:
- Article
Unwanted Hormonal and Metabolic Effects of Postoperative Adjuvant Mitotane Treatment for Adrenocortical Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2615, doi. 10.3390/cancers12092615
- By:
- Publication type:
- Article
DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Low-Dose Monitored Mitotane Treatment Achieves the Therapeutic Range with Manageable Side Effects in Patients with Adrenocortical Cancer.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2000, v. 85, n. 6, p. 2234, doi. 10.1210/jcem.85.6.6619
- By:
- Publication type:
- Article
Loss of Expression of the Ubiquitous Transcription Factor cAMP Response Element-Binding Protein (CREB) and Compensatory Overexpression of the Activator CREMτ in the Human Adrenocortical Cancer Cell Line H295R.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2000, v. 85, n. 1, p. 345, doi. 10.1210/jcem.85.1.6307
- By:
- Publication type:
- Article
Whole-genome and transcriptome analysis of advanced adrenocortical cancer highlights multiple alterations affecting epigenome and DNA repair pathways.
- Published in:
- Cold Spring Harbor Molecular Case Studies, 2022, v. 8, n. 3, p. 1, doi. 10.1101/mcs.a006148
- By:
- Publication type:
- Article
Limited Prognostic Value of the 2004 International Union Against Cancer Staging Classification for Adrenocortical Carcinoma.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Immediate versus modified release hydrocortisone in mitotane-treated patients with adrenocortical cancer.
- Published in:
- Clinical Endocrinology, 2017, v. 86, n. 4, p. 499, doi. 10.1111/cen.13302
- By:
- Publication type:
- Article
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism.
- Published in:
- Clinical Endocrinology, 2016, v. 84, n. 4, p. 614, doi. 10.1111/cen.12868
- By:
- Publication type:
- Article
Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Manual for Adrenocortical Carcinoma.
- Published in:
- World Journal of Surgery, 2020, v. 44, n. 2, p. 544, doi. 10.1007/s00268-019-05136-2
- By:
- Publication type:
- Article
F-FDG Uptake at Initial Staging of the Adrenocortical Cancers: A Diagnostic Tool but Not of Prognostic Value.
- Published in:
- World Journal of Surgery, 2013, v. 37, n. 1, p. 107, doi. 10.1007/s00268-012-1802-y
- By:
- Publication type:
- Article
[sup 11] C-metomidate PET imaging of adrenocortical cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 3, p. 403, doi. 10.1007/s00259-002-1025-9
- By:
- Publication type:
- Article
microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges.
- Published in:
- Frontiers in Endocrinology, 2016, p. 1, doi. 10.3389/fendo.2015.00195
- By:
- Publication type:
- Article
MicroRNAs as potential biomarkers in adrenocortical cancer: progress and challenges.
- Published in:
- Frontiers in Endocrinology, 2015, v. 6, p. 1, doi. 10.3389/fendo.2015.00195
- By:
- Publication type:
- Article
The Immunotherapy Landscape in Adrenocortical Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2660, doi. 10.3390/cancers13112660
- By:
- Publication type:
- Article
Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 724, doi. 10.3390/cancers12030724
- By:
- Publication type:
- Article
New Findings on Presentation and Outcome of Patients With Adrenocortical Cancer: Results From a National Cohort Study.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 10, p. 2517, doi. 10.1210/clinem/dgad199
- By:
- Publication type:
- Article
Massive Biochemically Silent Pheochromocytoma Masquerading as Nonfunctioning Adrenocortical Cancer.
- Published in:
- JCEM Case Reports, 2023, v. 1, n. 3, p. 1, doi. 10.1210/jcemcr/luad061
- By:
- Publication type:
- Article
Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG).
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 3, p. N.PAG, doi. 10.1016/j.clgc.2024.102077
- By:
- Publication type:
- Article
New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line.
- Published in:
- European Journal of Clinical Investigation, 2000, v. 30, p. 76, doi. 10.1046/j.1365-2362.2000.0300s3076.x
- By:
- Publication type:
- Article
The new histological system for the diagnosis of adrenocortical cancer.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1218686
- By:
- Publication type:
- Article
Silencing Mutated <i>β-Catenin</i> Inhibits Cell Proliferation and Stimulates Apoptosis in the Adrenocortical Cancer Cell Line H295R.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055743
- By:
- Publication type:
- Article